Search results

586 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC Blood Research Center 2020 Seminar Speaker Series presents Dr. Vijay M. Rao on Friday March 13th, 2020
UNC Blood Research Center 2020 Seminar Speaker Series
Located in Vital Signs / 2020 / Feb. 27
UNC Broadcast of IHI National Forum
The IHI National Forum on Quality Improvement in Health Care is a four-day conference that many attend in Orlando each December. UNC will offer a livestream broadcast of the conference, Dec. 10-11.
Located in Employee News Online / 2019 / Nov. 14
UNC Cancer Network Community Lunch and Learn Lecture- Colorectal Cancer: What You Need to Know
Please join the UNC Cancer Network for an online community lunch and learn lecture with Tammy Triglianos, ANP, AOCNP. Colorectal cancer is the fourth most common cancer in the U.S., with about 143,000 new patients diagnosed last year. Thanks to increased awareness about screenings, the death rate from colorectal cancer has been dropping for more than 20 years. Please join for this talk for an overview of colorectal cancer that information about prevention, screening, diagnosis and treatment, and survivorship.
Located in Vital Signs / 2018 / March 15
UNC Cancer Network Community Lunch and Learn Lecture– Addressing Palliative Care Needs of Children with Cancer
Please join the UNC Cancer Network for an online, interactive lecture with Elisabeth P. Dellon, MD, MPH. Community Lunch and Learn lectures are geared toward cancer patients, survivors, family, friends, and care givers/supports but anyone interested in learning more about cancer is welcome to join us. Every lecture has a question and answer section at the end so feel free to ask the presenter for clarification or more information. While these lectures are viewable online, we recommend watching them at one of our Community Lunch and Learn sites. Please contact us for more information and for assistance locating a site near you.
Located in Vital Signs / 2018 / April 19
UNC Cancer Network Medical and Surgical Oncology Lecture– Acute Myeloid Leukemia (AML): Finally Making Progress?
Please join the UNC Cancer Network for an online telehealth lecture with Joshua Zeidner, MD. Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants. We invite anyone interested to view our lectures. Lectures are viewable online via Zoom Webinar or by participating in the lecture at one of our designated viewing sites. Please contact us for more information about Zoom Webinar registration or to be connected with a site coordinator near you.
Located in Vital Signs / 2018 / May 17
UNC Cancer Network Medical and Surgical Oncology Lecture- Advances in Melanoma Cancer Treatment
Please join the UNC Cancer Network for an online telehealth lecture with Frances Collichio, MD. With the recent drug approvals, new treatment options have emerged for Melanoma that provide promise for improved outcomes. This lecture will share these breakthrough advances and discuss next steps and other advances that may be on the horizon. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants.
Located in Vital Signs / 2017 / Nov. 2
UNC Cancer Network Medical and Surgical Oncology Lecture- Metastatic Breast Cancer 2017
Please join the UNC Cancer Network for an online telehealth lecture with Claire Dees, MD. Dr. Dees will discuss treatments for metastatic breast cancer and advances in treatment that may lead to increases in overall survival and improvements in quality of life. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants.
Located in Vital Signs / 2017 / Nov. 30
UNC Cancer Network Medical and Surgical Oncology Lecture– Using Biomarkers to Plan Adjuvant Therapy in Breast Cancer
Please join the UNC Cancer Network for an online telehealth lecture with Lisa Carey, MD. Dr. Carey will discuss the anatomic and genomic variables that impact on (neo)adjuvant decision-making in breast cancer and the current treatment algorithms that allow rational escalation and de-escalation of systemic therapy. Medical and Surgical Oncology lectures offer FREE CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants. We invite anyone interested to view our lectures. Lectures are viewable online via Zoom Webinar or by participating in the lecture at one of our designated viewing sites. Please contact us for more information about Zoom Webinar registration or to be connected with a site coordinator near you.
Located in Vital Signs / 2018 / June 21
UNC Cancer Network Medical and Surgical Oncology Lecture- The Role of Radiation in Advanced and Metastatic Disease
Please join the UNC Cancer Network for an online telehealth lecture with Kevin Pearlstein, MD. Radiation therapy is a successful, time-efficient, well-tolerated, and cost-effective intervention that can be crucial for the appropriate delivery of care for patients with advanced and metastatic disease This lecture will explore current standards of care and promising advances with this type of treatment. Medical and Surgical Oncology lectures offer CNE, ASRT, and CME continuing education credit (upon approval) for eligible participants.
Located in Vital Signs / 2017 / Oct. 5
UNC Cancer Network Medical and Surgical Oncology Lecture– Tumor Treating Fields for Glioblastoma
Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift.
Located in Employee News Online / 2018 / Sept. 20